Filing Details

Accession Number:
0001209191-14-051260
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-08-07 19:51:08
Reporting Period:
2014-08-07
Filing Date:
2014-08-07
Accepted Time:
2014-08-07 18:51:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
949699 Pharmacyclics Inc PCYC Pharmaceutical Preparations (2834) 943148201
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1559226 Jesse Mcgreivy C/O Pharmacyclics, Inc.
995 East Arques Avenue
Sunnyvale CA 94085
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-08-07 3,645 $25.33 3,645 No 4 M Direct
Common Stock Acquisiton 2014-08-07 18,750 $89.52 22,395 No 4 M Direct
Common Stock Acquisiton 2014-08-07 11,667 $61.60 34,062 No 4 M Direct
Common Stock Disposition 2014-08-07 34,062 $120.92 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-08-07 3,645 $0.00 3,645 $25.33
Common Stock Stock Option (Right to Buy) Disposition 2014-08-07 11,667 $0.00 11,667 $61.60
Common Stock Common Stock Disposition 2014-08-07 18,750 $0.00 18,750 $89.52
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
15,313 2012-04-16 2022-04-16 No 4 M Direct
23,333 2013-04-11 2026-10-26 No 4 M Direct
56,250 2013-07-09 2023-07-09 No 4 M Direct
Footnotes
  1. The shares subject to the option will vest as follows: 25% of the shares subject to the option will vest on April 16, 2013 and 1/36th of the remaining shares will vest monthly thereafter.
  2. The option vests 6/48 on April 11, 2013; the remainder vests proportionately on each of April 11, 2014, April 11, 2015 and April 11, 2016. The vesting of the options are subject to satisfaction of certain performance criteria.
  3. The shares subject to the option will vest as follows: 25% of the shares subject to the option will vest on each of July 9, 2014, July 9, 2015; July 9, 2016; July 9, 2017. The vesting of the options is subject to satisfaction of certain performance criteria.